Univ.-Prof. Dr. Christoph Johannes Heinrich Rademacher, B.Sc. M.Sc.

2025S

• 301843 UE Practical Course in Molecular and Cellular Immunobiology
• 322029 VU Ausgewählte Kapitel aus der pharmazeutisch-technologischen Forschung - M13
• 322575 VO Pharmazeutische Nanotechnologie - Lipid-basierte Applikationen - M7/M14
• 323104 VU Biophysics in Drug Discovery - MPS5
• 323151 VU Fragment-based Drug Design - MPS10

2024W

• 301817 VO MPM 7 - Lecture course: Model systems in precision medicine - in the context of signature diseases
• 301818 SE MPM 7 - Seminar, Journal Club and Case Studies: Model systems in precision medicine - in the context of signature diseases
• 301849 UE Scientific Practice in Molecular Microbiology, Ecology or Immunobiology
• 322029 VU Ausgewählte Kapitel aus der pharmazeutisch-technologischen Forschung - M13
• 322072 VO Drug Targeting - Controlled delivery to target tissues - M7/M14
• 322575 VO Pharmazeutische Nanotechnologie - Lipid-basierte Applikationen - M7/M14

2024S

• 301813 VO MPM 3 - Lecture course: Fundamentals of enzymology, diseases and their clinical manifestation - manifestation, and technologies to correct enzymatic insufficiency
• 301818 VO MPM 7 - Lecture course: Clinical trial design
• 301843 UE Practical Course in Molecular and Cellular Immunobiology
• 301861 UE Wahlbeispiel Molekulare Biologie II
• 322025 VU Ausgewählte Kapitel aus der pharmazeutisch-technologischen Forschung - M13
• 322575 VO Pharmazeutische Nanotechnologie - Lipid-basierte Applikationen - M7/M14
• 323104 VU Biophysics in Drug Discovery - MPS5
• 323151 VU Fragment-based Drug Design - MPS10